|Articles|January 1, 2002

Symposium Reporter - Lipid Management
Volume 8
Issue 1 Symp

Lipid-Lowering Therapy Stabilizes Plaque Reduces Events by Limiting Inflammation

Author(s)Peter Libby, MD

Download PDF: Lipid-Lowering Therapy Stabilizes Plaque Reduces Events by Limiting Inflammation

Articles in this issue

over 24 years ago

Article

Cholesterol Goals Established for Patients with Diabetes and Metabolic Syndrome

over 24 years ago

Article

Dyslipidemia of Insulin Resistance Syndrome Explained; Need for Treatment to Reduce Risk Emphasized

over 24 years ago

Article

Review of Clinical trial Data Reaffirms Safety of Statin Therapy

over 24 years ago

Article

Protective Effects of HDL-C and Need to Raise Low Levels Explored

over 24 years ago

Article

Risk Factors Common to Insulin Resistance and Atherosclerosis Explain Why Diabetes is a Cardiovascular Disease

over 24 years ago

Article

Question and Answer

over 24 years ago

Article

Heart Protection Study Finds Simvastatin Reduces Vascular Risk in a Wide Range of High-Risk Patients

over 24 years ago

Article

New Cholesterol Guidelines Emphasize Risk Assessment

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

The Effect of Medicaid Reimbursement for Psychiatrists on the Health Care Burden of Serious Mental Illness

ByOnur Baser, PhD, MS,Heidi C. Waters, PhD,Nehir Yapar, BS,Gabriela Samayoa, MD, MPH,Xue Han, PhD,Deborah Freedman, MBA,Lauren Isenman, MPH,Rashmi Patel, MD, PhD

June 12th 2026

Association of Travel Nursing With Quality Outcomes in Hospitalized Patients

ByJason Bartock, MD,Adam Green, MD,Raquel Nahra, MD,Amy Bordogna, MD,Amir Davoodi, MD,Jean-Sebastien Rachoin, MD

June 11th 2026

Cost of Behavioral Messaging Interventions for Cardiovascular Medication Adherence

ByDana R. Fletcher, PhD,Lisa M. Sandy, MA,Joy Waughtal, MPH,Cole Hoffman, MS,Sylvie Novins-Montague, BA,Patrick Hosokawa, MS,Pamela N. Peterson, MD, MSPH,Larry A. Allen, MD, MPH,Sheana Bull, PhD,P. Michael Ho, MD, PhD

June 10th 2026

Changes in Persistence to Basal Insulin Following the Medicare Out-of-Pocket Cost Cap

ByRazanne Oueini, PharmD,Ben Shirley, BS,Christie Teigland, PhD,Melissa Castora-Binkley, PhD, MA,Scott Bilder, PhD,Kiran Sunkari, MS,Lynn Pezzullo, RPh

June 8th 2026

US map with stethoscope | Image Credit: © Andreas Prott - stock.adobe.com

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

ByShifeng Wu, MM

June 5th 2026

Lipid-Lowering Therapy Stabilizes Plaque Reduces Events by Limiting Inflammation

Articles in this issue

Related Content

The Effect of Medicaid Reimbursement for Psychiatrists on the Health Care Burden of Serious Mental Illness

Association of Travel Nursing With Quality Outcomes in Hospitalized Patients

Cost of Behavioral Messaging Interventions for Cardiovascular Medication Adherence

Changes in Persistence to Basal Insulin Following the Medicare Out-of-Pocket Cost Cap

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

Trending on AJMC

COVID-19 May Follow a Different Seasonal Pattern Than Influenza, RSV

New Bill Would Cap Traditional Medicare Out-of-Pocket Costs at $5000

Topical Delgocitinib Improves Chronic Hand Eczema Outcomes Across All Trial Timepoints

FDA Expands Risankizumab Approval to Pediatric Plaque Psoriasis, Active PsA

COA Offers Playbook to Help Community Oncology Practices Navigate AI Partnerships